Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2026-02-25 @ 5:34 PM
Study NCT ID:
NCT02758132
Status:
TERMINATED
Last Update Posted:
2019-11-08
First Post:
2016-04-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases
Sponsor:
University of Hawaii
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Rosser 2015-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None